Otto 2008.

Trial name or title	Exposure, D‐Cycloserine Enhancement, and Genetic Modulators in Panic Disorder
Methods	Double‐blind, randomised placebo controlled trial
Participants	192 patients who meet criteria for panic disorder, will be followed for over 5 years
Interventions	Patient with panic disorder will randomly receive DCS or placebo 1 hour prior to sessions 3 to 5 of a 5‐session CBT protocol that includes 2 additional booster sessions over the course of follow‐up
Outcomes	MADRS, CGI
Starting date	April 2008
Contact information	Michael Otto, National Institute on Drug Abuse
Notes	Phase 2 Study ID: NCT00790868